Michael M. Altaweel

Has grant

Professor

University of Wisconsin-Madison
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael M. Altaweel is a Professor at the University of Wisconsin Madison, USA. His research primarily focuses on the fields of uveitis, retinal diseases, and ocular oncology, as evidenced by his recent articles on macular edema treatments, gene expression in uveal melanoma, and outcomes of vitrectomy procedures. He is dedicated to advancing clinical knowledge and improving patient care in ophthalmology through rigorous research and collaboration.

Recent Grants

Grant: Close

ADalimimab Vs conventional ImmunoSupprEssion for uveitis (ADVISE) Trial

Open Date: 2018-09-30

Close Date: 2024-08-31

Grant: Close

Macular Edema Treatment Trials Associated with MUST (META-MUST)

Open Date: 2014-09-30

Close Date: 2023-01-31

Grant: Close

MUST Competitive Renewal

Open Date: 2004-07-15

Close Date: 2016-04-30

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Ezekiel Weis

University of Alberta

CANADA
View details

Stephen Russell

Dina J. Schrage Professor for Macular Degeneration Research

University of Iowa Healthcare

UNITED STATES
View details

Kathryn Pepple

Associate Professor

University of Washington

UNITED STATES
View details

J. William Harbour

Professor and Chair

University of Texas Southwestern Medical Center

UNITED STATES
View details

Kathleen Schildroth

University of Wisconsin-Madison

UNITED STATES
View details

Karim Jamal

CPA Chair Professor

University of Alberta

CANADA
View details

Jonathan Chang

University of Wisconsin-Madison

UNITED STATES
View details

prithvi mruthyunjaya

Stanford University

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.